Literature DB >> 28274727

Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults.

G Mulè1, A Castiglia2, M Morreale2, G Geraci2, C Cusumano2, L Guarino2, D Altieri2, M Panzica2, F Vaccaro2, S Cottone2.   

Abstract

BACKGROUND AND AIMS: In experimental investigations conducted in rats, raising serum uric acid (SUA) levels resulted in the stimulation of intrarenal renin expression. Studies in humans exploring the association of SUA with plasma renin activity (PRA) yielded conflicting results. Moreover, little is known about the relationship of SUA with plasma aldosterone concentration (PAC). The study aimed to assess the relationship between SUA levels, PRA, and PAC and the influence of age, gender, body mass index (BMI), and hyperuricemia on these relationships in subjects with essential hypertension (EH). METHODS AND
RESULTS: We enrolled 372 hypertensive patients (mean age 45 ± 12 years, men 67%) with uncomplicated EH that was not pharmacologically treated. The study population was divided in tertiles according to SUA levels. While PRA did not differ significantly across the three tertiles, PAC was higher in subjects belonging to the uppermost tertile of SUA than those in the lower ones (p = 0.0429); however, this difference lost statistical significance after adjustment for age, sex, BMI, and serum creatinine. Univariate correlation analyses showed significant associations of SUA with PRA (r = 0.137; p = 0.008) and PAC (r = 0.179; p < 0.001). However, these relationships were not significant after correcting for confounding factors in multiple linear regression analyses. We did not observe statistically significant effect modification by gender, age, BMI, and hyperuricemia.
CONCLUSION: SUA levels are weakly associated with PRA and PAC in adults with untreated EH. These relationships were lost after adjustment for age, sex, BMI, and serum creatinine.
Copyright © 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial hypertension; Blood pressure; Essential hypertension; Plasma aldosterone; Plasma renin activity; Uric acid

Mesh:

Substances:

Year:  2016        PMID: 28274727     DOI: 10.1016/j.numecd.2016.12.008

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

2.  Elevated Serum Uric Acid is Associated with Rapid Decline in Kidney Function: A 10-Year Follow-Up Study.

Authors:  Kittrawee Kritmetapak; Suranut Charoensri; Rattrai Thaopanya; Chatlert Pongchaiyakul
Journal:  Int J Gen Med       Date:  2020-10-23

3.  Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out.

Authors:  Giuseppe Mulè; Emilio Nardi; Luigi Lattuca; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

4.  Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity.

Authors:  Charlotte D C C van der Heijden; Rob Ter Horst; Inge C L van den Munckhof; Kiki Schraa; Jacqueline de Graaf; Leo A B Joosten; A H Jan Danser; Mihai G Netea; Jaap Deinum; Joost Rutten; Niels P Riksen
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

Review 5.  Uric Acid and Hypertension: Prognostic Role and Guide for Treatment.

Authors:  Federica Piani; Arrigo F G Cicero; Claudio Borghi
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.